Literature DB >> 11493468

T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.

H Liu1, H Ye, A Dogan, R Ranaldi, R A Hamoudi, I Bearzi, P G Isaacson, M Q Du.   

Abstract

The development of gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a multistep process and can be clinico-pathologically divided into Helicobacter pylori-associated gastritis, low-grade tumors, and high-grade tumors. The molecular events underlying this progression are largely unknown. However, identification of the genes involved in MALT lymphoma-specific t(11;18)(q21;q21) and t(1;14)(p22;q32) has provided fresh insights into the pathogenesis of this disease. T(11;18)(q21;q21) results in a chimeric transcript between the API2 and the MALT1 genes, whereas t(1;14) (p22;q32) causes aberrant nuclear BCL10 expression. Significantly, nuclear BCL10 expression also occurs frequently in MALT lymphomas without t(1;14)(p22;q32), suggesting an important role for BCL10 in lymphoma development. Thirty-three cases of H pylori gastritis, 72 MALT lymphomas, and 11 mucosal diffuse large B-cell lymphomas (DLBCL) were screened for t(11;18)(q21;q21) by reverse transcription-polymerase chain reaction followed by sequencing. BCL10 expression in lymphoma cases was examined by immunohistochemistry. The API2--MALT1 fusion transcript was not detected in H pylori gastritis and mucosal DLBCL but was found in 25 of 72 (35%) MALT lymphomas of various sites. Nuclear BCL10 expression was seen in 28 of 53 (53%) of MALT lymphomas. Of the gastric cases, the largest group studied, the frequency of both t(11;18)(q21;q21) and nuclear BCL10 expression was significantly higher in tumors that showed dissemination to local lymph nodes or distal sites (14 of 18 = 78% and 14 of 15 = 93%, respectively) than those confined to the stomach (3 of 29 = 10% and 10 of 26 = 38%). Furthermore, t(11;18)(q21;q21) closely correlated with BCL10 nuclear expression. These results indicate that both t(11;18)(q21;q21) and BCL10 nuclear expression are associated with advanced MALT lymphoma and that their oncogenic activities may be related to each other. (Blood. 2001;98:1182-1187)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493468     DOI: 10.1182/blood.v98.4.1182

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis.

Authors:  Hidekazu Suzuki; Yoshimasa Saito; Toshifumi Hibi
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

2.  cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas.

Authors:  Shimin Hu; Ming-Qing Du; Sun-Mi Park; Allison Alcivar; Like Qu; Sanjeev Gupta; Jun Tang; Mathijs Baens; Hongtao Ye; Tae H Lee; Peter Marynen; James L Riley; Xiaolu Yang
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 3.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.

Authors:  M-Q Du; J C Atherton
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

4.  Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.

Authors:  Camille Lobry; Tatiana Lopez; Alain Israël; Robert Weil
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

Review 5.  Current status of gastric MALT lymphoma.

Authors:  T Wündisch; M Stolte
Journal:  Curr Gastroenterol Rep       Date:  2006-10

6.  Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

Authors:  Frédéric Charlotte; Kamal Doghmi; Nathalie Cassoux; Hongtao Ye; Ming-Qing Du; Michèle Kujas; Annette Lesot; George Mansour; Phuc Lehoang; Nicole Vignot; Frédérique Capron; Véronique Leblond
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

Review 7.  From MALT lymphoma to the CBM signalosome: three decades of discovery.

Authors:  Shaun Rosebeck; Aasia O Rehman; Peter C Lucas; Linda M McAllister-Lucas
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

Review 8.  Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?

Authors:  Lara M Kingeter; Brian C Schaefer
Journal:  Cell Signal       Date:  2009-09-19       Impact factor: 4.315

Review 9.  Molecular diagnosis in lymphoma.

Authors:  Adam Bagg
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

10.  Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.

Authors:  Monika Joshi; Hassan Sheikh; Kamal Abbi; Sarah Long; Kamal Sharma; Mark Tulchinsky; Elliot Epner
Journal:  Ther Adv Hematol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.